Dong-Oh Han

Title: Innovations of Dong-Oh Han

Introduction

Dong-Oh Han is a notable inventor based in Anyang-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target specific enzymes and herbal extracts for medical applications. With a total of two patents to his name, his work has the potential to impact the treatment of various health conditions.

Latest Patents

Dong-Oh Han's latest patents include a compound that inhibits the 11Beta-HSD1 enzyme and a pharmaceutical composition containing herbal extracts for the prevention and treatment of nephritis. The first patent describes a novel compound or its pharmaceutically acceptable salt that selectively inhibits the activity of the 11Beta-HSD1 enzyme. This compound can be effectively used as a therapeutic agent for conditions such as non-insulin dependent type II diabetes, insulin resistance, obesity, and metabolic syndrome. The second patent focuses on a pharmaceutical composition that utilizes herbal extracts, including Crataegi Fructus, Cinnamomi Cortex, Prunella Spica, and Equiseti Herba, to prevent and treat nephritis. This composition has shown promising therapeutic effects in nephritis models.

Career Highlights

Throughout his career, Dong-Oh Han has worked with reputable companies such as Ahn-gook Pharmaceutical Co., Ltd. and Bamichem Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Dong-Oh Han has collaborated with notable coworkers, including Jin Auh and Soon Kil Ahn. These collaborations have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Dong-Oh Han's contributions to pharmaceutical innovations, particularly in enzyme inhibition and herbal medicine, highlight his role as a significant inventor in the industry. His patents reflect a commitment to advancing medical treatments and improving health outcomes.